UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 105

Sortiert nach

Active Surveillance in Prostate Cancer: Role of Available Biomarkers in Daily Practice

International journal of molecular sciences, 2021-06, Vol.22 (12), p.6266

2021

Volltextzugriff (PDF)

Prostate Cancer and the Mevalonate Pathway

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2152

2024

Volltextzugriff (PDF)

A risk‐organised model for clinically significant prostate cancer early detection

BJUI compass, 2023-07, Vol.4 (4), p.420-422

2023

Volltextzugriff (PDF)

A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand

Cancers, 2022-10, Vol.14 (20), p.5100

2022

Volltextzugriff (PDF)

Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer

European urology open science (Online), 2023-07, Vol.53, p.46-54

2023

Volltextzugriff (PDF)

A Stepwise Algorithm for Linearly Combining Biomarkers under Youden Index Maximization

Mathematics (Basel), 2022-04, Vol.10 (8), p.1221

2022

Volltextzugriff (PDF)

The True Utility of Predictive Models Based on Magnetic Resonance Imaging in Selecting Candidates for Prostate Biopsy

European urology open science (Online), 2022-08, Vol.42, p.40-41

2022

Volltextzugriff (PDF)

Investigating Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer

Journal of personalized medicine, 2024-01, Vol.14 (2), p.130

2024

Volltextzugriff (PDF)

Testicular fibroma of gonadal stromal origin in an adult male

Iberoamerican journal of medicine, 2023-11, Vol.6 (1), p.33-38

2023

Volltextzugriff (PDF)

A multistate model and its standalone tool to predict hospital and ICU occupancy by patients with COVID-19

Heliyon, 2023-02, Vol.9 (2), p.e13545-e13545, Article e13545

2023

Volltextzugriff (PDF)

Clinical and Surgical Assistance in Prostate Cancer during the COVID-19 Pandemic: Implementation of assistance protocols

International Brazilian journal of urology, 2020-07, Vol.46 (suppl.1), p.50-61

2020

Volltextzugriff (PDF)

External validation of the barcelona magnetic resonance imaging predictive model for detecting significant prostate cancer including men receiving 5-alpha reductase inhibitors

World journal of urology, 2024-07, Vol.42 (1), p.393, Article 393

2024

Volltextzugriff (PDF)

Clinical utility of thrombophilia, anticoagulant treatment, and maternal variables as predictors of placenta-mediated pregnancy complications: an extensive analysis

The journal of maternal-fetal & neonatal medicine, 2021-02, Vol.34 (4), p.588-598

2021

Volltextzugriff (PDF)

Reducing the demand for magnetic resonance imaging scans and prostate biopsies during the early detection of clinically significant prostate cancer: Applying the Barcelona risk-stratified pathway in Catalonia

Urologic oncology, 2024-04, Vol.42 (4), p.115.e1-115.e7

2024

Volltextzugriff (PDF)

Validation of a 2‐gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening population

The Prostate, 2020-05, Vol.80 (6), p.500-507

2020

Volltextzugriff (PDF)

Lymphoepithelioma-like bladder tumor. A rare variant.

Archivos españoles de urología, 2022-04, Vol.75 (3), p.300-305

2022

Volltextzugriff (PDF)

Comparison of fetal weight distribution improved by paternal height by Spanish standard versus Intergrowth 21st standard

Journal of perinatal medicine, 2018-09, Vol.46 (7), p.750

2018

Volltextzugriff (PDF)

How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies

World journal of urology, 2020-06, Vol.38 (6), p.1481-1491

2020

Volltextzugriff (PDF)

Teaching Urology to Undergraduates: A Prospective Survey of What General Practitioners Need to Know

International journal of environmental research and public health, 2021-11, Vol.18 (21), p.11687

2021

Volltextzugriff (PDF)

Implementing the use of nomograms by choosing threshold points in predictive models: 2012 updated Partin Tables vs a European predictive nomogram for organ‐confined disease in prostate cancer

BJU international, 2014-06, Vol.113 (6), p.878-886

2014

Volltextzugriff (PDF)

Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance

Prostate cancer and prostatic diseases, 2019-03, Vol.22 (1), p.84-90

2019

Volltextzugriff (PDF)

Validation and Comparison of Prognostic Models in Renal Carcinoma in a Tertiary Hospital

Archivos españoles de urología, 2024-07, Vol.77 (6), p.622

2024

Volltextzugriff (PDF)

The management of active surveillance in prostate cancer: validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry

Oncotarget, 2017-12, Vol.8 (65), p.108451-108462

2017

Volltextzugriff (PDF)

Re: Prognostic Nomogram for Renal Insufficiency After Radical or Partial Nephrectomy

The Journal of urology, 2007, Vol.177 (3), p.1201-1203

Borque, Ángel

2007

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(102)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Active Surveillance in Prostate Cancer: Role of Available Biomarkers in Daily Practice

Prostate Cancer and the Mevalonate Pathway

A risk‐organised model for clinically significant prostate cancer early detection

A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand

Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer

A Stepwise Algorithm for Linearly Combining Biomarkers under Youden Index Maximization

The True Utility of Predictive Models Based on Magnetic Resonance Imaging in Selecting Candidates for Prostate Biopsy

Investigating Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer

Testicular fibroma of gonadal stromal origin in an adult male

A multistate model and its standalone tool to predict hospital and ICU occupancy by patients with COVID-19

Clinical and Surgical Assistance in Prostate Cancer during the COVID-19 Pandemic: Implementation of assistance protocols

Epidemiology, Diagnosis and Management of Penile Cancer: Results from the Spanish National Registry of Penile Cancer

External validation of the barcelona magnetic resonance imaging predictive model for detecting significant prostate cancer including men receiving 5-alpha reductase inhibitors

Clinical utility of thrombophilia, anticoagulant treatment, and maternal variables as predictors of placenta-mediated pregnancy complications: an extensive analysis

Reducing the demand for magnetic resonance imaging scans and prostate biopsies during the early detection of clinically significant prostate cancer: Applying the Barcelona risk-stratified pathway in Catalonia

Validation of a 2‐gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening population

Lymphoepithelioma-like bladder tumor. A rare variant.

Comparison of fetal weight distribution improved by paternal height by Spanish standard versus Intergrowth 21st standard

How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies

Teaching Urology to Undergraduates: A Prospective Survey of What General Practitioners Need to Know

Implementing the use of nomograms by choosing threshold points in predictive models: 2012 updated Partin Tables vs a European predictive nomogram for organ‐confined disease in prostate cancer

Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance

Validation and Comparison of Prognostic Models in Renal Carcinoma in a Tertiary Hospital

The management of active surveillance in prostate cancer: validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry

Re: Prognostic Nomogram for Renal Insufficiency After Radical or Partial Nephrectomy

Suchergebnisse filtern